癌症支持療法產品市場:各藥物類別，各適應症，各流通管道，各地區-規模，佔有率，展望，機會分析，2023年～2030年

Cancer Supportive Care Products Market, By Drug Class, By Indication, By Distribution Channel, and By Region- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年03月28日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

癌症支持性護理與為患有各種類型癌症的患者提供的護理相關。支持性治療旨在減輕患者的痛苦並改善他們的生活品質。癌症是最普遍的致命慢性疾病之一，由於其侵襲性和病程長，死亡率很高。癌症的高患病率、研究和開發增加以及對生物製藥產業投資增加預計將在預測期內推動市場成長。

對全球癌症支持性護理產品的需求正在增加，因此預計將在預測期內推動市場成長。例如，根據美國疾病控制中心(CDC)的資料，到2022年，美國醫院中的醫療保健相關感染(HAI)每年導致170萬例感染和99,000例死亡。在所有感染中，尿路感染佔所有醫療保健獲得性感染的32%，其次是手術部位感染[22%]、肺炎[15%]和血液感染[14%]。

本報告對全球癌症支持護理產品市場進行了深入分析，並提供了預測期(2023-2030年)的市場規模(百萬美元)和年複合成長率(CAGR%)，以 2022年為基準年

Cancer supportive care is associated with care given to patients suffering from various types of cancer. Supportive care is intended for relieving the suffering of the patients and improving their quality of life. Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. The high prevalence of cancer, increasing research and development along with increasing investment in the biopharmaceutical industry is anticipated to drive the market growth during the forecast period.

Market Dynamics

The demand for the global cancer supportive care products is increasing and because of this it is expected to drive the market growth over the forecast period . For instance, In 2022, according to the Centers for Disease Control (CDC), Healthcare-associated infections (HAIs) in American hospitals are responsible for 1.7 million infections and 99,000 deaths occur per year. Out of all the infections, urinary tract infections occur up to 32% of all healthcare-acquired infections, followed by surgical site infections [22%], pneumonia [15%], and bloodstream infections[14%].

Key features of the study:

This report provides in-depth analysis of the Global Cancer Supportive Care Products market and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Cancer Supportive Care Products market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Amgen Inc., Johnson & Johnson Private Ltd., Merck, Novartis AG, Baxter International, Hoffmann-La Roche Ltd., Fagron, Teva Pharmaceutical Industries Ltd., G1 Therapeutics Inc., APR Applied Pharma Research s.a., Acacia Pharma, EMD Serono, and Kyowa Hakko Kirin Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Cancer Supportive Care Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cancer Supportive Care Products marke

Detailed Segmentation:

Global Cancer Supportive Care Products Market, By Drug Class:
- Nonsteroidal Anti- Inflammatory Drugs
- Anti-Infective
- Anti-Emetics
- Monoclonal Antibodies
- Erythropoietin Stimulating Agents
- Opioid Analgesics
- Bisphosphonates
- Granulocyte Colony Stimulating Factor
Global Cancer Supportive Care Products Market, By Indication:
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Bladder Cancer
- Leukemia
- Ovary Cancer
- Melanoma Cancer
- Others
Global Cancer Supportive Care Products Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Compounding Pharmacies
Global Cancer Supportive Care Products Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC Countries
- Israel
- Rest of Middle East
- Africa
  - By Country:
- North Africa
- Central Africa
- South Africa
Company Profiles
- Amgen Inc.*
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Johnson & Johnson Private Ltd.
- Merck
- Novartis AG
- Baxter International
- F.Hoffmann-La Roche Ltd.
- Fagron
- Teva Pharmaceutical Industries Ltd.
- G1 Therapeutics Inc.
- APR Applied Pharma Research S.A.
- Acacia Pharma
- EMD Serono
- Kyowa Hakko Kirin Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Snapshot ,By Map
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Impact Analysis
Financial Overview
Product launch
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions

4. Global Cancer Supportive Care Products Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Cancer Supportive Care Products Market, By Drug Class, 2017 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Nonsteroidal Anti- Inflammatory Drugs Class
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Anti-Infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Anti-Emetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Erythropoietin Stimulating Agents
- Introduction
- Market Size and Forecast , and Y-o-Y Growth, 2017-2030, (US$ Million)
Opioid Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Bisphosphonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Granulocyte Colony Stimulating Factor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Cancer Supportive Care Products Market, By Indication, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Ovary Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Melanoma Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Cancer Supportive Care Products Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

Introduction
- Y-o-Y Growth Analysis, 2017 - 2030
- Market Share Analysis, 2023 and 2030 (%)
- Segments Trends
Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Cancer Supportive Care Products Market, By Region, 2017- 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs Class , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Amgen Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Johnson & Johnson Private Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Merck
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Novartis AG.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Baxter International.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Fagron
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
G1 Therapeutics Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
APR Applied Pharma Research S.A
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Acacia Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
EMD Serono
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies